Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $4.38 Million - $5.7 Million
-111,151 Reduced 44.0%
141,492 $5.77 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $92,977 - $121,371
-2,227 Reduced 0.87%
252,643 $13 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $6.12 Million - $7.47 Million
-139,807 Reduced 35.42%
254,870 $11.2 Million
Q2 2022

Aug 17, 2022

SELL
$46.53 - $55.17 $1.22 Million - $1.44 Million
-26,164 Reduced 6.22%
394,677 $20.7 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $1.41 Million - $1.75 Million
-30,795 Reduced 6.82%
420,841 $21.8 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $16.5 Million - $24.5 Million
399,197 Added 761.26%
451,636 $26.7 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $2.06 Million - $2.64 Million
52,439 New
52,439 $2.26 Million
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $837,497 - $1.2 Million
-30,984 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $493,503 - $560,063
-14,991 Reduced 32.61%
30,984 $1.21 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $18,356 - $23,803
-565 Reduced 1.21%
45,975 $1.65 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $1.72 Million - $1.93 Million
46,540 New
46,540 $2.02 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.